Today we’re looking at the use of continuous glucose monitoring devices (CGMs) for both type 1 and type 2 diabetes. Claire Levy talks with Jake Leach, the chief operating officer of CGM developer and manufacturer Dexcom, from their US headquarters in San Diego, California.